Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 8/20 | 0.51 |
| ▸ | ITGA2B | P08514 | 8/20 | 0.51 |
| ▸ | F2R | P25116 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | BMP1 | P13497 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7501495 | 0.94 | ITGB3 (0.49) | ITGB3ITGA2BF2RALDH1A1MEN1 | |
| SCHEMBL7501795 | 0.87 | ITGB3 (0.54) | ITGB3ITGA2BF2RALDH1A1KMT2A | |
| SCHEMBL7500231 | 0.87 | ITGB3 (0.45) | ITGB3ITGA2BF2RALDH1A1KMT2A | |
| SCHEMBL7492120 | 0.86 | ITGB3 (0.47) | ITGB3ITGA2BF2RALDH1A1MEN1 | |
| SCHEMBL7846012 | 0.86 | ITGB3 (0.60) | ITGB3ITGA2BF2RALDH1A1MEN1 | |
| SCHEMBL7498497 | 0.85 | ITGB3 (0.48) | ITGB3ITGA2BF2RALDH1A1MEN1 | |
| SCHEMBL7503555 | 0.84 | ITGB3 (0.47) | ITGB3ITGA2BF2RKMT2A | |
| SCHEMBL7501491 | 0.84 | ITGB3 (0.54) | ITGB3ITGA2BF2RALDH1A1MEN1 | |
| Hydrochloric Acid SCHEMBL7502230 | 0.84 | ITGB3 (0.53) | ITGB3ITGA2BF2RALDH1A1MEN1 | |
| SCHEMBL7496757 | 0.83 | ITGB3 (0.47) | ITGB3ITGA2BF2RALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1106606-A2 | N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-06-13 | — | — | EP | disclosed |
| EP-0669912-A1 | N-(3-PIPERIDINYLCARBONYL)-BETA-ALANINE DERIVATIVES AS PAF ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-09-06 | — | — | EP | disclosed |
| WO-1995008536-A1 | N-(3-PIPERIDINYLCARBONYL)-BETA-ALANINE DERIVATIVES AS PAF ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-03-30 | — | — | WO | disclosed |